| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0140-6736(91)90014-G |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:014067369190014G?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:014067369190014G?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 1676092 |
| P2093 | author name string | P. Fells | |
| P2860 | cites work | Treatment of strabismus in adults with botulinum toxin A. | Q33644462 |
| Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach | Q33647383 | ||
| Eyelid malpositions in Graves' ophthalmopathy | Q34212396 | ||
| Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy | Q35706662 | ||
| Correlation of CT scanning and pathologic features of ophthalmic Graves' disease | Q41470422 | ||
| Orbital decompression for severe dysthyroid eye disease | Q42615337 | ||
| Orbital decompression for Graves' ophthalmopathy by inferomedial, by inferomedial plus lateral, and by coronal approach | Q45235954 | ||
| Supervoltage orbital radiotherapy for Graves' ophthalmopathy | Q67249584 | ||
| Diagnosis and management of dysthyroid exophthalmos | Q67730385 | ||
| Prognostic factors in the radiotherapy of Graves' ophthalmopathy | Q68353384 | ||
| Botulinum toxin therapy in dysthyroid strabismus | Q68582284 | ||
| Diplopia in thyroid eye disease | Q68745213 | ||
| Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy | Q69288448 | ||
| The four stages of surgical rehabilitation of the patient with dysthyroid ophthalmopathy | Q69498905 | ||
| Diagnosis and Treatment of Thyroid Myopathy | Q70885385 | ||
| Transorbital approach to decompression in Graves' disease | Q71851954 | ||
| Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction | Q72142198 | ||
| P433 | issue | 8758 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 29-32 | |
| P577 | publication date | 1991-07-01 | |
| 1991-07-06 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Thyroid-associated eye disease: clinical management | |
| P478 | volume | 338 |
| Q70674539 | A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves ophthalmopathy |
| Q74821669 | An ultrastructural and systemic analysis of glycosaminoglycans in thyroid-associated ophthalmopathy |
| Q73870904 | Antioxidant agents in the treatment of Graves' ophthalmopathy |
| Q37303872 | Contrast sensitivity function in Graves' ophthalmopathy and dysthyroid optic neuropathy |
| Q34394088 | Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. |
| Q72459769 | Extraocular muscle problems in thyroid eye disease |
| Q73048088 | Hyperthyroidism |
| Q34059445 | Natural history of thyroid associated ophthalmopathy |
| Q35221491 | Radiotherapy and ophthalmology: time for a friendly re-acquaintance |
| Q34154222 | Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts. |
| Q78723650 | Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16 Gy |
| Q35314277 | T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy |
| Q40511567 | Thyroid-associated ophthalmopathy: pathogenesis and clinical management. |
| Q43674410 | Thyroid-associated orbitopathy developed during hormone replacement therapy |
Search more.